Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - iron as iron dextran; vitamin a palmitate; vitamin d3 = cholecalciferol; tocopheryl acetate (vitamin e) - parenteral liquid/solution/suspension - iron as iron dextran mineral-iron active 100.0 mg/ml; vitamin a palmitate vitamin-a other 10000.0 iu/ml; vitamin d3 = cholecalciferol vitamin-d3 other 1000.0 iu/ml; tocopheryl acetate (vitamin e) vitamin-e other 10.0 mg/l - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - iron supplement

United States - English - NLM (National Library of Medicine)

exeltis usa, inc. - vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin d (unii: 9vu1ki44gp) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) - vitamin a 1100 [iu] - vitafol® fe+ prenatal supplement is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron supplementation is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - iron dextran complex - parenteral liquid/solution/suspension - iron dextran complex mineral-iron active 200.0 mg/ml - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - anaemia | iron deficiency | anaemia

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

pharmacosmos a/s - iron dextran complex - parenteral liquid/solution/suspension - iron dextran complex mineral-iron active 200.0 mg/ml - nutrition & metabolism

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - iron as iron dextran; cyanocobalamin (vitamin b12) - parenteral liquid/solution/suspension - iron as iron dextran mineral-iron active 200.0 mg/ml; cyanocobalamin (vitamin b12) vitamin-b12 active 40.0 ug/ml - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - anaemia | iron deficiency | anaemia

United States - English - NLM (National Library of Medicine)

exeltis usa, inc. - vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin d (unii: 9vu1ki44gp) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochloride (unii: 68y4cf58bv) - vitafol® fe+ prenatal supplement is contraindicated in patients with hypersensitivity to any of its components or color additives. folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. iron supplementation is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver. cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin b12).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bec feed solutions pty ltd - ferric oxide colloidal; vitamin b12 = cyanocobalamin - parenteral liquid/solution/suspension - ferric oxide colloidal mineral-iron active 100.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 75.0 ug/ml - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - iron & haemopoietic agent | anaemia | haemopoietic agents | hematinic | iron deficiency

New Zealand - English - Ministry for Primary Industries

elanco new zealand - vitamin a; iron present as iron dextran; cholecalciferol; vitamin e - vitamin a 5.88 g/litre; iron present as iron dextran 100 g/litre; cholecalciferol 0.03 g/litre; vitamin e 10 g/litre - parenteral nutrient/electrolyte

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - iron as iron carbonyl and ferric pyrophosphate; vitamin b2 = riboflavin; vitamin b1 nitrate = thiamine nitrate; cobaltous sulfate heptahydrate; glycine; lysine hydrochloride; methionine-dl; copper carbonate; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b6 hydrochloride = pyridoxine hydrochloride; vitamin m = folic acid = pga - oral granules, pellets - iron as iron carbonyl and ferric pyrophosphate mineral-iron active 230.0 mg/30g; vitamin b2 = riboflavin vitamin-b2 active 25.0 mg/30g; vitamin b1 nitrate = thiamine nitrate vitamin-b1 active 15.0 mg/30g; cobaltous sulfate heptahydrate mineral-cobalt other 1.0 mg/30g; glycine amino acid-glycine other 100.0 mg/30g; lysine hydrochloride amino acid-lysine other 200.0 mg/30g; methionine-dl amino acid-methionine-dl other 100.0 mg/30g; copper carbonate mineral-copper-salt other 18.0 mg/30g; vitamin b12 = cyanocobalamin vitamin-b12 other 500.0 mg/30g; vitamin b3 = nicotinamide vitamin-b3 other 300.0 mg/30g; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 other 15.0 mg/30g; vitamin m = folic acid = pga vitamin-m other 7.5 mg/30g - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - iron deficiency | mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | anaemia | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - norethindrone acetate (unii: 9s44lic7oj) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone acetate 1 mg - microgestin ® 1/20, microgestin ® fe 1/20 , microgestin ® 1.5/30, and microgestin ® fe 1.5/30 are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease cerebral vascular or coronary artery dise